ENTPD1 (CD39) and NT5E (CD73) expression in human medulloblastoma: an in silico analysis-Reference-Cited by-同舟云学术

ENTPD1 (CD39) and NT5E (CD73) expression in human medulloblastoma: an in silico analysis

Published:2024-07-08 Issue: Volume: Page:
ISSN:1573-9538
Container-title:Purinergic Signalling
language:en
Short-container-title:Purinergic Signalling

Author:

Stefani Marco Antônio^ORCID,Braganhol Elizandra^ORCID,Santos Guilherme Tomasi^ORCID,Suwa Samuel Masao^ORCID,Cabeleira Daiane Dias^ORCID,de Andrade Guilherme Pamplona Bueno^ORCID

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11302-024-10035-w.pdf

Reference27 articles.

1. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106

2. Millard NE, De Braganca KC (2016) Medulloblastoma. J Child Neurol 31(12):1341–53. https://doi.org/10.1177/0883073815600866. Epub 2015 Sep 2. Erratum in: J Child Neurol. 2016 Sep 15

3. Packer RJ, Cogen P, Vezina G, Rorke LB (1999) Medulloblastoma: clinical and biologic aspects. Neuro Oncol 1(3):232–250. https://doi.org/10.1093/neuonc/1.3.232

4. Huybrechts S, Le Teuff G, Tauziède-Espariat A, Rossoni C, Chivet A, Indersie É, Varlet P, Puget S, Abbas R, Ayrault O, Guerrini-Rousseau L, Grill J, Valteau-Couanet D, Dufour C (2020) Prognostic clinical and biologic features for overall survival after relapse in childhood medulloblastoma. Cancers (Basel) 13(1):53. https://doi.org/10.3390/cancers13010053

5. Zhang B (2010) CD73: a novel target for cancer immunotherapy. Cancer Res 70(16):6407–6411. https://doi.org/10.1158/0008-5472.CAN-10-1544